Login / Signup

Oral Absorbent AST-120 Is Associated with Compositional and Functional Adaptations of Gut Microbiota and Modification of Serum Short and Medium-Chain Fatty Acids in Advanced CKD Patients.

Cheng-Kai HsuShih-Chi SuLun-Ching ChangKai-Jie YangChin-Chan LeeHeng-Jung HsuYih-Ting ChenChiao-Yin SunI-Wen Wu
Published in: Biomedicines (2022)
Advanced CKD patients exhibited significant gut dysbiosis. AST-120 can partially restore the gut microbiota and intervenes in a possible signature of short- and medium-chain fatty acids metabolism.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • fatty acid
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis